We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aeglea’s Enzyme Pegzilarginase Normalizes Plasma Arginine in 90 Percent of Patients in Late-Stage Study
Aeglea’s Enzyme Pegzilarginase Normalizes Plasma Arginine in 90 Percent of Patients in Late-Stage Study
Aeglea BioTheraputics hopes to snag a first-in-class approval for its recombinant human enzyme pegzilarginase after finding that the molecule normalized plasma arginine levels in more than 90 percent of patients with ARG1-D, an inability to process the protein.